Womens Imaging: Page 177

How has the ACA affected breast cancer screening?

By Kate Madden Yee

Debate has raged over the impact of the Patient Protection and Affordable Care Act (ACA) of 2010 on access to healthcare services. However, at least one hospital in California found that the ACA didn't necessarily change access to screening mammography, according to a new study published in the American Journal of Surgery.

January 28, 2019

DBT is comparable to FFDM for detecting benign lesions

By Kate Madden Yee

Digital breast tomosynthesis (DBT) is comparable to full-field digital mammography (FFDM) for identifying benign breast lesions, according to a new study published online January 23 in the American Journal of Roentgenology.

January 28, 2019

Digital breast tomosynthesis wins support in Middle East

By Dr. Nehad Kazim Albastaki

In daily clinical practice, digital breast tomosynthesis offers real and important benefits over conventional 2D mammography, Dr. Nehad Kazim Albastaki from Abu Dhabi, United Arab Emirates, told delegates on the opening day of the Total Radiology conference at Arab Health 2019.

January 27, 2019

Breast MRI effective as adjunct to DBT in high-risk women

By Kate Madden Yee

Breast MRI is an effective adjunct screening technology for women at high risk for breast cancer who had negative results on full-field digital mammography or digital breast tomosynthesis (DBT) exams, according to a study published in the February issue of the American Journal of Roentgenology.

January 24, 2019

CAD boosts reader performance for breast ultrasound

By Kate Madden Yee

Using computer-aided diagnosis (CAD) with breast ultrasound improves the diagnostic performance of both less-experienced and experienced breast imagers, according to a study by researchers from South Korea that was published in the January issue of Medicine.

January 24, 2019

Racial factors affect time to breast cancer treatment

By Kate Madden Yee

Black women with breast cancer experienced longer times to surgery than their white counterparts in a study among patients in the U.S. Military Health System published online January 23 in JAMA Surgery.

January 23, 2019

Breast MRI helps guide DCIS treatment

By Kate Madden Yee

Breast MRI -- along with tests that characterize breast cancer genes -- can help guide treatment for patients with ductal carcinoma in situ (DCIS), according to a study published online January 17 in JAMA Oncology.

January 20, 2019

Week in Review: Breast MRI predicts cancer risk | AI for glioblastoma | Make time for SalaryScan

By Brian Casey

January 18, 2019

FDA clears Hologic's Localizer for long-term placement

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared women's imaging firm Hologic's Localizer radiofrequency identification breast lesion localization device for long-term placement.

January 17, 2019

DBT finds more invasive, early-stage cancers

By Kate Madden Yee

Digital breast tomosynthesis (DBT) finds 13% more invasive and early-stage cancers in women with dense tissue than conventional 2D mammography, according to a study published in the January issue of the Korean Journal of Radiology.

January 15, 2019

Screening mammo critic Gotzsche to start new institute

By AuntMinnie.com staff writers

Long-time mammography screening critic Dr. Peter Gøtzsche plans to start a new organization called the Institute for Scientific Freedom, according to a news item published online January 11 in the BMJ.

January 14, 2019

Tissue enhancement on breast MRI informs cancer risk

By Kate Madden Yee

Elevated levels of background parenchymal enhancement on breast MRI increase a woman's risk of developing invasive breast cancer -- even more than breast tissue density does, according to a study published online January 9 in the Journal of Clinical Oncology.

January 13, 2019

Previous Page

Page 177 of 701

Next Page